HomeNews & TopicsInfection ControlHPV vaccination switch to 1-dose gender-neutral approach

HPV vaccination switch to 1-dose gender-neutral approach

Published on

Canadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and eliminate cervical cancer, suggests new modelling in CMAJ (Canadian Medical Association Journal).

“Our results have important policy implications in Canada, and in other similar high-income countries evaluating whether to switch to 1-dose HPV vaccination,” writes Dr. Marc Brisson, a full professor at Laval University, Québec, and director of the Mathematical Modeling and Health Economics of Infectious Diseases Lab at the Centre de recherche du CHU de Québec–Université Laval.

Countries around the world are looking at whether to move from a 2-dose to 1-dose HPV vaccination approach after a 2022 recommendation by the World Health Organization Strategic Advisory Group of Experts on Immunization based on clinical trial evidence. Human papillomavirus can cause cervical cancer and other diseases.

Researchers in Ontario and Quebec modelled various scenarios based on 1- and 2-dose approaches to inform recommendations from the Canadian National Advisory Committee on Immunization and the Comité sur l’immunisation du Québec.

The group found that 1-dose gender-neutral vaccination could prevent a similar number of cervical cancers as 2 doses, if vaccine protection remains high during ages of peak sexual activity. “[A]ll 1-dose vaccination scenarios, even the most pessimistic, were projected to be a substantially more efficient use of vaccine doses than 2-dose vaccination; these scenarios were also all projected to lead to elimination of cervical cancer in Canada between 2032 and 2040,” write the authors.

This approach is a more efficient use of vaccine doses and is projected to help eliminate cervical cancer in Canada.

“The COVID-19 pandemic impacted HPV vaccination in Canada, particularly among vulnerable population subgroups. The potential economic savings by switching to 1-dose vaccination, and its programmatic flexibility, could allow investments to increase vaccination uptake in regions where coverage is suboptimal and in high HPV burden subgroups to mitigate the pandemic’s impact on programs and to reduce inequalities,” said Dr. Chantal Sauvageau, specialist in community health and consultant in infectious diseases at the National Institute of Public Health in the province of Quebec.

Regular monitoring of 1-dose protection is advised to detect signs of waning protection.

“Switching from a 2-dose to a 1-dose program of gender-neutral routine vaccination against human papillomavirus in Canada: a mathematical modelling analysis” is published October 7, 2024.

Latest articles

Helping Canada Design Health Care Facilities for Future Needs

Health care facilities (HCFs) play an important role in communities, providing a safe, secure,...

Improving wound microcirculation

Chronic wounds on the lower leg and foot have multiple etiologies that include vascular...

Alcohol-related deaths up 18% during pandemic

Alcohol-related deaths increased 18% during the pandemic, as did hospitalizations related to alcohol use,...

The Canadian Consensus Statement on the management of venous leg ulcers

This Consensus Statement was developed with the objective of creating a concise document that...

More like this

Alcohol-related deaths up 18% during pandemic

Alcohol-related deaths increased 18% during the pandemic, as did hospitalizations related to alcohol use,...

Child undernutrition may be contributing to global measles outbreaks, researchers find

Amid a global surge in measles cases, new research suggests that undernutrition may be...

Research suggests link between COVID-19 vaccine hesitancy and increasing uncertainty in routine vaccines for young children

A study published last week, Parental Factors Associated With Measles–Mumps–Rubella Vaccination in US Children Younger...

Are anxiety and depression useful predictors of heart disease risk?

Adding measures of anxiety and depression to a commonly used cardiovascular risk predictor would...

Provinces need to come together now to make pharmacare a reality for all Canadians

With a federal election looming, we need swift action to make pharmacare a reality...

The role of healthcare in mitigating the climate crisis

The role of healthcare in mitigating the climate crisis By Wendy Levinson Canada signed the historic...